AAPL295.16+0.86 (+0.29%) ▲|ABBV235.99+1.23 (+0.52%) ▲|ABT91.02+0.49 (+0.54%) ▲|ACN131.54+4.53 (+3.57%) ▲|ADBE198.19+0.76 (+0.38%) ▲|AMAT572.84-13.05 (-2.23%) ▼|AMD509.53-10.32 (-1.99%) ▼|AMGN353.95+6.94 (+2.00%) ▲|AMT176.00-3.39 (-1.89%) ▼|AMZN236.21+2.10 (+0.90%) ▲|AVGO378.48-1.67 (-0.44%) ▼|AXP342.60+4.82 (+1.43%) ▲|BA220.65+3.94 (+1.82%) ▲|BAC57.78-0.13 (-0.23%) ▼|BKNG183.37+14.43 (+8.54%) ▲|BLK982.75-32.58 (-3.21%) ▼|BMY55.37-0.17 (-0.30%) ▼|BNY144.52-2.77 (-1.88%) ▼|BRK-B496.68+3.87 (+0.79%) ▲|C144.28-0.70 (-0.48%) ▼|CAT983.20-1.04 (-0.11%) ▼|CL92.22+0.79 (+0.86%) ▲|CMCSA22.75-0.05 (-0.22%) ▼|COF201.05+3.24 (+1.64%) ▲|COP107.10-2.87 (-2.61%) ▼|COST963.05+5.37 (+0.56%) ▲|CRM153.40-0.02 (-0.01%) ▼|CSCO119.49-1.67 (-1.37%) ▼|CVS101.98+0.41 (+0.40%) ▲|CVX171.94-4.04 (-2.30%) ▼|DE606.99+15.05 (+2.54%) ▲|DHR188.36+9.39 (+5.25%) ▲|DIS102.21-1.33 (-1.28%) ▼|DUK126.22+1.17 (+0.94%) ▲|EMR141.50-1.64 (-1.15%) ▼|FDX312.70-4.54 (-1.43%) ▼|GD346.22-4.12 (-1.18%) ▼|GE364.90+8.43 (+2.36%) ▲|GEV1,046.92+11.94 (+1.15%) ▲|GILD126.28+1.23 (+0.98%) ▲|GM79.63+0.68 (+0.86%) ▲|GOOG344.30-1.79 (-0.52%) ▼|GOOGL345.01-1.08 (-0.31%) ▼|GS1,077.37-17.08 (-1.56%) ▼|HD342.02+17.57 (+5.41%) ▲|HON227.46+5.09 (+2.29%) ▲|IBM263.77-1.17 (-0.44%) ▼|INTC129.49-2.79 (-2.11%) ▼|INTU264.67+6.62 (+2.57%) ▲|ISRG402.91-0.27 (-0.07%) ▼|JNJ240.94+1.86 (+0.78%) ▲|JPM334.18+0.04 (+0.01%) ▲|KO81.03+0.72 (+0.89%) ▲|LIN517.40+5.14 (+1.00%) ▲|LLY1,113.52+6.44 (+0.58%) ▲|LMT494.83-8.84 (-1.76%) ▼|LOW221.49+7.95 (+3.72%) ▲|LRCX363.54-7.80 (-2.10%) ▼|MA495.99+7.92 (+1.62%) ▲|MCD275.28+3.62 (+1.33%) ▲|MDLZ62.10+1.04 (+1.70%) ▲|MDT80.59-0.04 (-0.05%) ▼|META559.09-3.11 (-0.55%) ▼|MMM166.36+4.52 (+2.79%) ▲|MO72.23+0.62 (+0.87%) ▲|MRK121.48+1.88 (+1.57%) ▲|MS221.42-4.61 (-2.04%) ▼|MSFT368.72-5.22 (-1.40%) ▼|MU1,006.32-45.46 (-4.32%) ▼|NEE87.53+1.10 (+1.27%) ▲|NFLX72.42-0.41 (-0.56%) ▼|NKE41.91-0.48 (-1.12%) ▼|NOW93.78-2.17 (-2.26%) ▼|NVDA197.64-2.36 (-1.18%) ▼|ORCL157.02-8.14 (-4.93%) ▼|PEP142.76+0.71 (+0.50%) ▲|PFE24.16-0.57 (-2.29%) ▼|PG152.44+1.58 (+1.05%) ▲|PLTR113.59-3.11 (-2.67%) ▼|PM179.60+0.91 (+0.51%) ▲|QCOM193.42-10.71 (-5.25%) ▼|RTX185.96-0.43 (-0.23%) ▼|SBUX104.20+3.15 (+3.12%) ▲|SCHW91.48-1.69 (-1.81%) ▼|SO95.67+0.74 (+0.77%) ▲|SPG221.90+5.16 (+2.38%) ▲|T22.49-0.33 (-1.42%) ▼|TMO491.05+21.70 (+4.62%) ▲|TMUS182.73-1.84 (-1.00%) ▼|TSLA375.70-5.91 (-1.55%) ▼|TXN303.25-1.11 (-0.36%) ▼|UBER74.03+4.36 (+6.25%) ▲|UNH405.82-3.43 (-0.84%) ▼|UNP260.75+2.14 (+0.83%) ▲|UPS105.22-0.62 (-0.58%) ▼|USB60.23+0.18 (+0.30%) ▲|V332.91+4.43 (+1.35%) ▲|VZ45.85-0.88 (-1.88%) ▼|WFC84.29+0.16 (+0.18%) ▲|WMT119.64+0.22 (+0.18%) ▲|XOM136.44-3.30 (-2.36%) ▼|AAPL295.16+0.86 (+0.29%) ▲|ABBV235.99+1.23 (+0.52%) ▲|ABT91.02+0.49 (+0.54%) ▲|ACN131.54+4.53 (+3.57%) ▲|ADBE198.19+0.76 (+0.38%) ▲|AMAT572.84-13.05 (-2.23%) ▼|AMD509.53-10.32 (-1.99%) ▼|AMGN353.95+6.94 (+2.00%) ▲|AMT176.00-3.39 (-1.89%) ▼|AMZN236.21+2.10 (+0.90%) ▲|AVGO378.48-1.67 (-0.44%) ▼|AXP342.60+4.82 (+1.43%) ▲|BA220.65+3.94 (+1.82%) ▲|BAC57.78-0.13 (-0.23%) ▼|BKNG183.37+14.43 (+8.54%) ▲|BLK982.75-32.58 (-3.21%) ▼|BMY55.37-0.17 (-0.30%) ▼|BNY144.52-2.77 (-1.88%) ▼|BRK-B496.68+3.87 (+0.79%) ▲|C144.28-0.70 (-0.48%) ▼|CAT983.20-1.04 (-0.11%) ▼|CL92.22+0.79 (+0.86%) ▲|CMCSA22.75-0.05 (-0.22%) ▼|COF201.05+3.24 (+1.64%) ▲|COP107.10-2.87 (-2.61%) ▼|COST963.05+5.37 (+0.56%) ▲|CRM153.40-0.02 (-0.01%) ▼|CSCO119.49-1.67 (-1.37%) ▼|CVS101.98+0.41 (+0.40%) ▲|CVX171.94-4.04 (-2.30%) ▼|DE606.99+15.05 (+2.54%) ▲|DHR188.36+9.39 (+5.25%) ▲|DIS102.21-1.33 (-1.28%) ▼|DUK126.22+1.17 (+0.94%) ▲|EMR141.50-1.64 (-1.15%) ▼|FDX312.70-4.54 (-1.43%) ▼|GD346.22-4.12 (-1.18%) ▼|GE364.90+8.43 (+2.36%) ▲|GEV1,046.92+11.94 (+1.15%) ▲|GILD126.28+1.23 (+0.98%) ▲|GM79.63+0.68 (+0.86%) ▲|GOOG344.30-1.79 (-0.52%) ▼|GOOGL345.01-1.08 (-0.31%) ▼|GS1,077.37-17.08 (-1.56%) ▼|HD342.02+17.57 (+5.41%) ▲|HON227.46+5.09 (+2.29%) ▲|IBM263.77-1.17 (-0.44%) ▼|INTC129.49-2.79 (-2.11%) ▼|INTU264.67+6.62 (+2.57%) ▲|ISRG402.91-0.27 (-0.07%) ▼|JNJ240.94+1.86 (+0.78%) ▲|JPM334.18+0.04 (+0.01%) ▲|KO81.03+0.72 (+0.89%) ▲|LIN517.40+5.14 (+1.00%) ▲|LLY1,113.52+6.44 (+0.58%) ▲|LMT494.83-8.84 (-1.76%) ▼|LOW221.49+7.95 (+3.72%) ▲|LRCX363.54-7.80 (-2.10%) ▼|MA495.99+7.92 (+1.62%) ▲|MCD275.28+3.62 (+1.33%) ▲|MDLZ62.10+1.04 (+1.70%) ▲|MDT80.59-0.04 (-0.05%) ▼|META559.09-3.11 (-0.55%) ▼|MMM166.36+4.52 (+2.79%) ▲|MO72.23+0.62 (+0.87%) ▲|MRK121.48+1.88 (+1.57%) ▲|MS221.42-4.61 (-2.04%) ▼|MSFT368.72-5.22 (-1.40%) ▼|MU1,006.32-45.46 (-4.32%) ▼|NEE87.53+1.10 (+1.27%) ▲|NFLX72.42-0.41 (-0.56%) ▼|NKE41.91-0.48 (-1.12%) ▼|NOW93.78-2.17 (-2.26%) ▼|NVDA197.64-2.36 (-1.18%) ▼|ORCL157.02-8.14 (-4.93%) ▼|PEP142.76+0.71 (+0.50%) ▲|PFE24.16-0.57 (-2.29%) ▼|PG152.44+1.58 (+1.05%) ▲|PLTR113.59-3.11 (-2.67%) ▼|PM179.60+0.91 (+0.51%) ▲|QCOM193.42-10.71 (-5.25%) ▼|RTX185.96-0.43 (-0.23%) ▼|SBUX104.20+3.15 (+3.12%) ▲|SCHW91.48-1.69 (-1.81%) ▼|SO95.67+0.74 (+0.77%) ▲|SPG221.90+5.16 (+2.38%) ▲|T22.49-0.33 (-1.42%) ▼|TMO491.05+21.70 (+4.62%) ▲|TMUS182.73-1.84 (-1.00%) ▼|TSLA375.70-5.91 (-1.55%) ▼|TXN303.25-1.11 (-0.36%) ▼|UBER74.03+4.36 (+6.25%) ▲|UNH405.82-3.43 (-0.84%) ▼|UNP260.75+2.14 (+0.83%) ▲|UPS105.22-0.62 (-0.58%) ▼|USB60.23+0.18 (+0.30%) ▲|V332.91+4.43 (+1.35%) ▲|VZ45.85-0.88 (-1.88%) ▼|WFC84.29+0.16 (+0.18%) ▲|WMT119.64+0.22 (+0.18%) ▲|XOM136.44-3.30 (-2.36%) ▼|
27.5 C
New York
Wednesday, June 24, 2026

Tag: vision

newssourceFORcompanyinformationcontent1marketreleases

Autoket Rebrands As Supply Veins, Relaunching As An AI-Powered Communications Platform to Revolutionize B2B Procurement Across All Industries

The Supply Veins Co-Founder and CEO is a PenFed Foundation for Military Heroes Veteran Entrepreneur Program Alumnus Multimedia: VIDEO LINK MIAMI, Aug. 1, 2025 /PRNewswire/ -- Autoket,...

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)

Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.1 Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a  global healthcare company advancing biomedical innovations to improve health and wellness...

SUBARU OF AMERICA REPORTS JULY SALES UP 4.5 PERCENT

Best-ever July for CrosstrekBest month ever for SolterraForester sales up 11.3 percentOutback sales up 5.5 percentCAMDEN, N.J., Aug. 1, 2025 /PRNewswire/ -- Subaru of America, Inc. (SOA)...

Experity Appoints Bobby Ghoshal as President and Chief Operating Officer

CHICAGO, Aug. 1, 2025 /PRNewswire/ -- Experity, the national leader in on-demand healthcare solutions, today announced the appointment of Bobby Ghoshal as President and Chief...

Launching With Life to Catalyze Global Regenerative Movement

First-of-its-kind community learning platform and nonprofit initiative empowering leaders to advocate for systemic change worldwide BOULDER, Colo., Aug. 1, 2025 /PRNewswire/ -- In response to today's...

DeFi Cattos Unveils the Core Engine Powering Sustainable Web3 Gaming on Aptos

SINGAPORE, Aug. 1, 2025 /PRNewswire/ -- The first real-time battle RPG on Aptos is setting a new standard for on-chain gameplay and player rewards. ...

MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2025

Clichy, le 1er août 2025 - L’Oréal annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers son Rapport financier semestriel au 30 juin 2025.

BIC : Déclaration Des Transactions Sur Actions Propres de Juillet 2025

Déclaration Des Transactions Sur Actions Propres
De Juillet 2025

VISION OF ‘ABILITIES BEYOND LIMITATIONS’ COMES TO LIFE AS STUDENTS WITH SPECIAL NEEDS HEAD BACK TO SCHOOL IN NEW SCHOOL FACILITY

Language And Literacy Academy For Learning Students And Leaders, City and County Officials, Building Hope Executives Cut Ribbon On New School Facility In Winter...

Protein Industries Canada and Nurasa Launch Program to Expand Global Reach of Canadian Plant-Based Companies into the Asia-Pacific Market

New Partnership will help Canadian food and ingredient companies diversify product offerings for Asia-Pacific Consumers 
New Partnership will help Canadian food and ingredient companies diversify product offerings for Asia-Pacific Consumers

Titan of Industry Allan Camaisa Teams Up with Res Nova Bio to Advance Breast Cancer Immunotherapy

Clinical Stage Biotechnology Company Uses Patient Immune System to "Seek and Destroy" Cancer and Metastasis SAN DIEGO, Aug. 1, 2025 /PRNewswire/ -- Res Nova Biologics,...

Mabwell Announces IND Application Acceptance for CDH17-Targeting ADC 7MW4911 from Both NMPA and FDA

SHANGHAI, Aug. 1, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911,...

Manufacturing PMI® at 48%; July 2025 Manufacturing ISM® Report On Business®

New Orders and Backlogs Contracting; Production Growing and Employment Contracting; Supplier Deliveries Faster; Raw Materials Inventories Contracting; Customers' Inventories Too Low; Prices Increasing; Exports...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsVision

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers